Home › Cardiovascular Disease › Oklahoma
Cardiovascular Disease clinical trials in Oklahoma
11 studies for Cardiovascular Disease are looking for participants at sites in Oklahoma.
Cities in Oklahoma
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- South Oklahoma Heart Research, LLC, Oklahoma City
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Edmond
- Clinical Trial Site, Moore
- Clinical Trial Site, Norman
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Tekton Research Oklahoma City, Oklahoma City
- South Oklahoma Heart Research Group, Oklahoma City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07064473Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- Integris Baptist Medical Center, Oklahoma City
Recruiting
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT03242642A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Oklahoma City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Alliance for Multispecialty Research, Norman
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Oklahoma Heart Institute, Tulsa
Recruiting
Ages 18 to 85 · All sexes · Updated Aug 18, 2026 · NCT07214376Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Integris Baptist Medical Center, Oklahoma City
- Oklahoma Heart Institute at Utica, Tulsa
- Saint Francis Hospital, Tulsa
Recruiting
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06526195The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Oklahoma Heart Institute Hospital, Tulsa
- Saint Francis Hospital,, Tulsa
Recruiting
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT03142152MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- University of Oklahoma Health Science Center, Oklahoma City
Recruiting
Ages 18 to 80 · All sexes · Updated Sep 11, 2025 · NCT06271590MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- Oklahoma University Health (OU Health), Oklahoma City
Recruiting
Ages 18 to 110 · All sexes · Updated Feb 25, 2025 · NCT05908331From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.